On-Demand Webcast

Share

Program Content

Activities

  • HER2+ MBC Novel Therapies
    Novel Therapies for Relapsed or Refractory HER2-Positive Metastatic Breast Cancer
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 11, 2020

    Expires: September 10, 2021

Provided by

ProCE Banner

Supporters

Daiichi Sankyo, Inc.